Brand Intelligence Graphcompany
Company Overview
About Henry Schein
Henry Schein is the world's largest provider of health care solutions to office-based dental and medical practitioners, founded in 1932 by Henry Schein in Queens, New York, and headquartered in Melville, New York. The company trades on Nasdaq (HSIC) and generated approximately $12.4 billion in net sales in 2024, serving over one million healthcare practitioners across more than 30 countries. Henry Schein operates through two segments: Health Care Distribution, supplying dental and medical consumables, equipment, and technology; and Technology and Value-Added Services, offering practice management software and digital dentistry solutions under brands like Dentrix, Dexis, and Axium.
Business Model & Competitive Advantage
The company suffered a major cybersecurity breach in October 2023 when the ALPHV/BlackCat ransomware group targeted its distribution systems, disrupting operations for several months and resulting in data theft affecting over 166,000 individuals. By mid-2024, Henry Schein had restored full operations and invested significantly in cybersecurity infrastructure, emerging with hardened network segmentation, enhanced endpoint detection, and new incident response protocols. The OneSource platform integrates procurement, practice management, and digital imaging into a unified workflow for dental and medical offices, creating switching costs that underpin recurring revenue.
Competitive Landscape 2025–2026
In 2025-2026, Henry Schein competes primarily with Patterson Companies (PDCO) in dental distribution and McKesson in medical supply. The digital dentistry revolution—encompassing intraoral scanners, CAD/CAM milling, and AI-assisted diagnosis—represents a significant growth vector, with Henry Schein's technology segment growing faster than distribution. Strategic investments in specialty dental networks and DSO (Dental Service Organization) partnerships aim to capture the consolidating dental market. The company also expanded its animal health distribution through Covetrus until its 2022 sale, allowing sharper focus on human health markets.
The Henry Schein Story
Founders
Recent Activity
View all →Company Timeline
Major milestones in Henry Schein's journey
Leadership Team
Meet the leaders behind Henry Schein
Stanley M. Bergman
Stanley Bergman has served as Chairman and CEO of Henry Schein since 1989, transforming the company from a $225 million barely profitable business into a global healthcare solutions giant with nearly $13 billion in annual revenue. Born in South Africa, Bergman came to New York in 1976 as an accountant, joined Henry Schein in 1980, and was promoted to CFO before becoming CEO. Under his 35+ year leadership, the company's market cap expanded from $290 million at its 1995 IPO to approximately $9 billion. He will retire as CEO at the end of 2025 while continuing as Chairman.
Ronald N. South
Ronald N. South has served as Senior Vice President and Chief Financial Officer of Henry Schein since 2022, overseeing the company's financial strategy, reporting, and capital allocation. He plays a key role in the company's strategic planning and has been instrumental in navigating the 2024-2025 restructuring and KKR investment.
Michael S. Ettinger
Michael S. Ettinger has been Chief Operating Officer and Executive Vice President of Henry Schein since 2022, responsible for operational excellence across the company's global distribution network and value-added services. He oversees the company's day-to-day operations and execution of strategic initiatives.
Andrea Albertini
Andrea Albertini was appointed CEO of the Global Distribution Group in 2024, with additional responsibility for the Global Technology Group. In this role, he leads the company's largest segment, which generated $10.8 billion in sales in 2024, overseeing dental and medical distribution as well as technology solutions.
Tom Popeck
Tom Popeck was appointed CEO of the Healthcare Specialties Group (HSG) in 2024, leading the segment that generated $1.4 billion in sales. He is responsible for the company's specialty healthcare products business and strategic growth initiatives in this high-margin segment.
Steve Boggan
Steve Boggan was appointed co-CEO of the Global Oral Reconstruction Group (GORG) in 2024, sharing leadership responsibility with Bianka Wilson. He oversees operations and strategic initiatives in the oral reconstruction and specialty dental equipment segment.
Bianka Wilson
Bianka Wilson was appointed co-CEO of the Global Oral Reconstruction Group (GORG) in 2024, sharing leadership with Steve Boggan. She brings extensive experience in healthcare and leads strategic initiatives for the oral reconstruction business.
Robert J. Hombach
Robert J. Hombach joined the Henry Schein Board as an independent director in January 2025 in connection with KKR's strategic investment. He brings extensive financial and strategic experience in healthcare, providing valuable governance oversight during the company's transformation.
Key Differentiators
Market Leader
Henry Schein is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Doximity
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinic
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
Compare Henry Schein with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Henry Schein? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Henry Schein Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Henry Schein vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →